Hrt Financial LP Nls Pharmaceutics Ltd. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$0.11 - $0.27 $1,851 - $4,544
16,832 New
16,832 $3,000
Q1 2022

May 16, 2022
SELL
$0.82 - $1.76 $11,502 - $24,689
-14,028 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.11 - $2.56 $15,571 - $35,911
14,028 New
14,028 $15,000

About NLS Pharmaceutics Ltd.

NLSP Quotes by TradingView
  • Ticker NLSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,349,900
  • Market Cap $55.5M
  • Description
  • NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...
More about NLSP
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email